NXEN
Nexien BioPharma, Inc.
0.0001
+0.0000+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
-/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
7.08K
P/E (TTM)
-
Basic EPS (TTM)
0.00
Dividend Yield
0%

Recent Filings

About 

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

CEO
Mr. Richard S. Greenberg
IPO
10/31/1994
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic